Literature DB >> 24917216

One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia.

Stefano Savonitto1, Nuccia Morici, Claudio Cavallini, Roberto Antonicelli, Anna Sonia Petronio, Ernesto Murena, Zoran Olivari, Giuseppe Steffenino, Francesco Bonechi, Antonio Mafrici, Anna Toso, Federico Piscione, Leonardo Bolognese, Stefano De Servi.   

Abstract

OBJECTIVES: To determine whether type 2 diabetes mellitus and hyperglycemia on admission should be considered independent predictors of mortality in elderly adults with acute coronary syndrome (ACS).
DESIGN: Prospective cohort study.
SETTING: Twenty-three hospitals in Italy. PARTICIPANTS: Individuals aged 75 and older with non-ST-elevation ACS (NSTEACS) (mean age 82, 47% female) (N = 645). MEASUREMENTS: Diabetic status and blood glucose levels were assessed on admission. Hyperglycemia was defined as glucose greater than 140 mg/dL. Multivariable Cox proportional hazard regression was used to assess the potential confounding effect of major covariates on the association between diabetic status, admission glucose, and 1-year mortality.
RESULTS: A history of diabetes mellitus was found in 231 participants (35.8%), whereas 257 (39.8%) had hyperglycemia. Hyperglycemia was found in 171 participants with diabetes mellitus (70%) and 86 (21%) without diabetes mellitus. Participants with diabetes mellitus were significantly (P < .05) more likely to have had prior myocardial infarction and stroke and had lower ejection fraction and blood hemoglobin. Hyperglycemia was associated with lower (P < .05) ejection fraction and estimated glomerular filtration rate (eGFR). Diabetic status and hyperglycemia were associated with greater 1-year mortality according to univariate analysis (54 participants with diabetes mellitus died (23.4%), versus 66 (15.9%) without diabetes mellitus (hazard ratio (HR) = 1.5 95% confidence interval (CI) = 1.0-2.1), and 60 participants with hyperglycemia died (23.3%), versus 60 (15.5%) without hyperglycemia (HR=1.6; 95% CI = 1.1-2.2), but this association was not statistically significant after adjustment for ejection fraction, age, blood hemoglobin, and eGFR.
CONCLUSION: In elderly adults with NSTEACS, diabetes mellitus and hyperglycemia on admission are associated with higher mortality, mostly because of preexisting cardiovascular and renal damage.
© 2014, Copyright the Authors Journal compilation © 2014, The American Geriatrics Society.

Entities:  

Keywords:  acute coronary syndrome; diabetes mellitus; elderly; hyperglycemia; mortality

Mesh:

Year:  2014        PMID: 24917216     DOI: 10.1111/jgs.12900

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

1.  Diabetes mellitus, revascularization and outcomes in elderly patients with myocardial infarction-related cardiogenic shock.

Authors:  Miquel Gual; Ariza Albert-Solé; Marí Garcaí Maárquez; Cristina Fernández; José L Bernal; Francesc Formiga; María-Isabel Barrionuevo; José C Sánchez-Salado; Victòria Lorente; Júlia Pascual; Isaac Llaó; Oriol Alegre; Angel Cequier; Javier Elola
Journal:  J Geriatr Cardiol       Date:  2020-10-28       Impact factor: 3.327

2.  One-year Mortality after an Acute Coronary Event and its Clinical Predictors: The ERICO Study.

Authors:  Itamar Souza Santos; Alessandra Carvalho Goulart; Rodrigo Martins Brandão; Rafael Caire de Oliveira Santos; Márcio Sommer Bittencourt; Débora Sitnik; Alexandre Costa Pereira; Carlos Alberto Pastore; Nelson Samesima; Paulo Andrade Lotufo; Isabela Martins Bensenor
Journal:  Arq Bras Cardiol       Date:  2015-05-08       Impact factor: 2.000

3.  Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.

Authors:  Takashi Miura; Atsushi Izawa; Hirohiko Motoki; Yusuke Miyashita; Yuichiro Kashima; Souichiro Ebisawa; Takeshi Tomita; Jun Koyama; Uichi Ikeda
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

4.  Prognostic value of glucose metabolism for non-ST-segment elevation infarction patients with diabetes mellitus and single concomitant chronic total occlusion following primary percutaneous coronary intervention.

Authors:  Zhi Xing; Lei Zhang; Zhiqiang Liu; Pengyi He; Yuchun Yang; Muhuyati Wulasihan
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

5.  Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Yuanyuan Hao; Qun Lu; Tao Li; Guodong Yang; Peijing Hu; Aiqun Ma
Journal:  BMC Cardiovasc Disord       Date:  2017-01-05       Impact factor: 2.298

6.  Does Diabetes Mellitus Increase the Short- and Long-Term Mortality in Patients With Critical Acute Myocardial Infarction? Results From American MIMIC-III and Chinese CIN Cohorts.

Authors:  Shiqun Chen; Zhidong Huang; Liling Chen; Xiaoli Zhao; Yu Kang; Wenguang Lai; Xiaozhao Lu; Yang Zhou; Yibo He; Haozhang Huang; Qiang Li; Jin Liu; Yan Liang; Shaohong Dong; Ning Tan; Yong Liu; Jiyan Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

7.  Impact of acute diabetes decompensation on outcomes of diabetic patients admitted with ST-elevation myocardial infarction.

Authors:  Mayada Issa; Fahad Alqahtani; Chalak Berzingi; Mohammad Al-Hajji; Tatiana Busu; Mohamad Alkhouli
Journal:  Diabetol Metab Syndr       Date:  2018-07-17       Impact factor: 3.320

8.  Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts.

Authors:  Slayman Obeid; Antonio H Frangieh; Lorenz Räber; Nooraldaem Yousif; Thomas Gilhofer; Kyohei Yamaji; Milosz Jaguszewski; Soheila Aghlmandi; James Adams; Yannik Bockhorn; Christian Templin; Barbara E Stähli; Peter Jüni; Nicolas Rodondi; François Mach; Marco Roffi; Stephan Windecker; Willibald Maier; Fabian Nietlispach; Christian M Matter; Roland Klingenberg; Thomas F Lüscher
Journal:  Cardiol Res Pract       Date:  2018-09-25       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.